Taperloc
Payments companies reported to CMS as associated with Taperloc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Taperloc, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Taperloc
These are the largest totals companies reported as associated with Taperloc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raul Gosthe | Miami, FL | Adult Reconstructive Orthopaedic Surgery | $59,850.00 |
| Jonathan Yerasimides | Louisville, KY | Orthopaedic Surgery | $58,917.18 |
| Atul Kamath | Manasquan, NJ | Adult Reconstructive Orthopaedic Surgery | $45,262.50 |
| Aldo Riesgo | Miami, FL | Orthopaedic Surgery | $39,087.50 |
| Giovanni Paraliticci | Miami, FL | Orthopaedic Surgery | $29,628.44 |
| Victor Hernandez | Miami, FL | Orthopaedic Surgery | $18,919.97 |
| Trevor Banka | Detroit, MI | Adult Reconstructive Orthopaedic Surgery | $16,875.00 |
| Thomas Donaldson | Colton, CA | Adult Reconstructive Orthopaedic Surgery | $13,125.00 |
| James Kyle | Lafayette, LA | Orthopaedic Surgery | $11,833.20 |
| Todd Sekundiak | Elkhorn, NE | Orthopaedic Surgery | $8,645.54 |
Prescribed Taperloc?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.